Nabla May Be the Inflection Point That Finally Fixes Physician Documentation
Overview: How Nabla’s AI‑Driven Medical Scribe Platform Transforms Clinical Documentation and Care Delivery Nabla is an AI medical scribe that captures clinician–patient conversations and automatically generates structured clinical documentation for electronic health records. It is designed to alleviate the longstanding bottleneck of manual note‑taking and data entry, where clinicians spend a significant portion of their […]
Feature Categories
Overview: How Nabla’s AI‑Driven Medical Scribe Platform Transforms Clinical Documentation and Care Delivery
Nabla is an AI medical scribe that captures clinician–patient conversations and automatically generates structured clinical documentation for electronic health records. It is designed to alleviate the longstanding bottleneck of manual note‑taking and data entry, where clinicians spend a significant portion of their day translating spoken encounters into coded, billable, and clinically useful records. By shifting this burden away from the point of care, Nabla aims to reduce the documentation overhead that contributes to time pressure and burnout, while keeping pace with demands for more complete, standardised notes.
At a high level, Nabla applies speech recognition, natural language processing, and large language models to multi‑speaker audio, identifying medically relevant facts, assessments, and plans, and then mapping them into structured note sections aligned with typical clinical workflows. The system is designed to distinguish conversational noise from clinically meaningful content and to produce drafts that require minimal editing rather than full re‑writing. In practice, this can shorten the time between an encounter and finalised documentation, reduce after‑hours work on notes, and support more consistent capture of key clinical details, which in turn can improve information continuity across teams and downstream use of documentation for quality improvement and analytics.
What is Nabla?
Nabla is an AI medical scribe that transcribes clinician–patient conversations and generates structured clinical notes for use in electronic health records, with primary use cases in automating visit documentation and reducing manual data entry. It is used by clinicians and healthcare organisations seeking to streamline documentation workflows and lessen administrative burden. Nabla is distinguished by its use of speech recognition and large language models tailored to clinical dialogue to extract medically relevant information and organise it into standard note formats that fit existing clinical workflows.
Why Leading Healthcare Teams Trust Nabla
-
Nabla has established strategic partnerships with large provider organisations, including The Permanente Medical Group in Northern California and Carle Health, to deploy its AI scribe across hospitals, practices, and emergency departments.
-
Nabla has entered a strategic integration with Navina, combining its ambient documentation with Navina’s clinical intelligence copilot to support value‑based care workflows and audit‑ready documentation.
-
The company reports adoption by over 50,000 clinicians, handling tens of thousands of encounters daily and securing dozens of enterprise contracts with health systems and academic centres, indicating real‑world scale and operational maturity.
-
Nabla has been recognised on the 2025 New York Digital Health 100 list, which highlights innovative and impactful digital health startups contributing to the New York healthcare innovation ecosystem.
-
Nabla’s Trust Centre and policies state adherence to HIPAA and GDPR requirements and reference alignment with SOC 2, ISO 27001, and NIST cybersecurity standards for security and privacy management.
-
The company indicates that it does not store audio by default and that medical data retention is time‑limited and configurable (for example, a 14‑day window), with options for de‑identified feedback, which reduces persistent data exposure.
-
Public materials emphasise that audio and clinical content are not retained indefinitely for model training, instead limiting secondary use of identifiable patient data and allowing clinicians control over feedback sharing.
-
Nabla has raised a reported total of around $120 million in venture funding, including a $70 million Series C round backed by established investors, which supports perceptions of financial stability and capacity for ongoing product development.
